4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-22-097135
Chief Executive Officer sold 2,536 shares at $1.97 ($4,993)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rawcliffe Adrian Chief Executive Officer | 2022-09-01 | Sale | −2,536 | $1.97 | $4,993 | 3,316 | D: show line 1 in the form |
| Open-market sales · 2,536 sh · avg $1.97 · $4,993 | |||||||
Loading xslF345X03/tm2224996-1_4seq1.xml…